Atrial fibrosis in embolic stroke of undetermined source: A multicenter study

Left atrial (LA) cardiac disease is a suspected cause of embolic stroke of undetermined source (ESUS). We tested the hypothesis that LA fibrosis, quantified using late‐gadolinium‐enhancement magnetic resonance imaging (LGE‐MRI), predicts recurrent stroke or atrial fibrillation (AF) in patients with ESUS.

[1]  D. Bluemke,et al.  Left Atrial Mechanical Function and Incident Ischemic Cerebrovascular Events Independent of AF: Insights From the MESA Study. , 2019, JACC. Cardiovascular imaging.

[2]  W. Longstreth,et al.  Embolic stroke of undetermined source correlates to atrial fibrosis without atrial fibrillation , 2019, Neurology.

[3]  H. Kamel,et al.  Tailoring the Approach to Embolic Stroke of Undetermined Source: A Review. , 2019, JAMA neurology.

[4]  J. Healey,et al.  Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial. , 2019, JAMA neurology.

[5]  K. Furie,et al.  Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source. , 2019, Stroke.

[6]  R. Sacco,et al.  Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source , 2019, The New England journal of medicine.

[7]  R. Kronmal,et al.  The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods , 2018, International journal of stroke : official journal of the International Stroke Society.

[8]  S. Connolly,et al.  Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source , 2018, The New England journal of medicine.

[9]  Hooman Kamel,et al.  Early Elevated Troponin Levels After Ischemic Stroke Suggests a Cardioembolic Source , 2018, Stroke.

[10]  Ana Catarina Fonseca,et al.  Patients With Undetermined Stroke Have Increased Atrial Fibrosis: A Cardiac Magnetic Resonance Imaging Study , 2018, Stroke.

[11]  Benjamin R. Kummer,et al.  Biomarkers of Atrial Cardiopathy and Atrial Fibrillation Detection on Mobile Outpatient Continuous Telemetry After Embolic Stroke of Undetermined Source. , 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[12]  S. Connolly,et al.  Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update , 2017, Stroke.

[13]  N. Akoum.  New perspectives on atrial fibrillation and stroke , 2016, Heart.

[14]  H. Kamel,et al.  Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model , 2016, Stroke.

[15]  J. Halperin,et al.  Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences. , 2015, Journal of the American College of Cardiology.

[16]  Natalia S. Rost,et al.  B-Type Natriuretic Peptides Help in Cardioembolic Stroke Diagnosis: Pooled Data Meta-Analysis , 2015, Stroke.

[17]  Frank Beckers,et al.  Cryptogenic stroke and underlying atrial fibrillation. , 2014, The New England journal of medicine.

[18]  David J Gladstone,et al.  Atrial fibrillation in patients with cryptogenic stroke. , 2014, The New England journal of medicine.

[19]  V. Chair,et al.  Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.

[20]  Timothy Watson,et al.  Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited , 2009, The Lancet.